Literature DB >> 27508533

Expanded Indian National Rotavirus Surveillance Network in the Context of Rotavirus Vaccine Introduction.

Sanjay Mehendale1, S Venkatasubramanian, C P Girish Kumar, Gagandeep Kang, M D Gupte, Rashmi Arora.   

Abstract

OBJECTIVE: To extend a nation-wide rotavirus surveillance network in India, and to generate geographically representative data on rotaviral disease burden and prevalent strains.
DESIGN: Hospital-based surveillance.
SETTING: A comprehensive multicenter, multi-state hospital based surveillance network was established in a phased manner involving 28 hospital sites across 17 states and two union territories in India. PATIENTS: Cases of acute diarrhea among children below 5 years of age admitted in the participating hospitals.
RESULTS: During the 28 month study period between September 2012 and December 2014, 11898 children were enrolled and stool samples from 10207 children admitted with acute diarrhea were tested; 39.6% were positive for rotavirus. Highest positivity was seen in Tanda (60.4%) and Bhubaneswar (60.4%) followed by Midnapore (59.5%). Rotavirus infection was seen more among children aged below 2 years with highest (46.7%) positivity in the age group of 12-23 months. Cooler months of September to February accounted for most of the rotavirus associated gastroenteritis, with highest prevalence seen during December to February (56.4%). 64% of rotaviru -infected children had severe to very severe disease. G1 P[8] was the predominant rotavirus strain (62.7%) during the surveillance period.
CONCLUSION: The surveillance data highlights the high rotaviral disease burden in India. The network will continue to be a platform for monitoring the impact of the vaccine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27508533     DOI: 10.1007/s13312-016-0891-3

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  7 in total

1.  Genotypic determination of human group A rotaviruses from Goa and Meghalaya states, India.

Authors:  Abhay Raorane; Zunjar Dubal; Sandeep Ghatak; Michael Mawlong; B Susngi; Virendra Gaonkar; Eknath Chakurkar; Sukhadeo Barbuddhe
Journal:  Heliyon       Date:  2020-08-19

2.  Rotavirus vaccine impact assessment surveillance in India: protocol and methods.

Authors:  Nayana P Nair; Samarasimha Reddy N; Sidhartha Giri; Venkata Raghava Mohan; Umesh Parashar; Jacqueline Tate; Minesh Pradyuman Shah; Rashmi Arora; Mohan Gupte; Sanjay M Mehendale; Gagandeep Kang
Journal:  BMJ Open       Date:  2019-04-25       Impact factor: 2.692

3.  Seasonal variation and etiologic inferences of childhood pneumonia and diarrhea mortality in India.

Authors:  Daniel S Farrar; Shally Awasthi; Shaza A Fadel; Rajesh Kumar; Anju Sinha; Sze Hang Fu; Brian Wahl; Shaun K Morris; Prabhat Jha
Journal:  Elife       Date:  2019-08-27       Impact factor: 8.140

4.  Multicountry Analysis of Spectrum of Clinical Manifestations of Children <5 Years of Age Hospitalized with Diarrhea.

Authors:  Jillian Murray; S Yati Soenarto; Nenny S Mulyani; Pushpa S Wijesinghe; Evans M Mpabalwani; Julia C Simwaka; Belem Matapo; Jason M Mwenda; Gayane Sahakyan; Svetlana Grigoryan; Artavazd Vanyan; Sergey Khactatryan; Jennifer Sanwogou; Lúcia Helena de Oliveira; Gloria Rey-Benito; Gagandeep Kang; Fatima Serhan; Jacqueline E Tate; Negar Aliabadi; Adam L Cohen
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

5.  Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India.

Authors:  C P Girish Kumar; Sidhartha Giri; Mamta Chawla-Sarkar; Varanasi Gopalkrishna; Shobha D Chitambar; Pratima Ray; S Venkatasubramanian; Biswajyoti Borkakoty; Subarna Roy; Jyothi Bhat; Bhagirathi Dwibedi; Vijayachari Paluru; Pradeep Das; Rashmi Arora; Gagandeep Kang; Sanjay M Mehendale
Journal:  Vaccine       Date:  2020-11-07       Impact factor: 3.641

Review 6.  Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation.

Authors:  Akash Malik; Pradeep Haldar; Arindam Ray; Anita Shet; Bhrigu Kapuria; Sheenu Bhadana; Mathuram Santosham; Raj Shankar Ghosh; Robert Steinglass; Rakesh Kumar
Journal:  Vaccine       Date:  2019-08-30       Impact factor: 3.641

7.  A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.

Authors:  Catherine Cohet; Brigitte Cheuvart; Leentje Moerman; Dan Bi; Adrian Caplanusi; Mallesh Kariyappa; Sanjay Lalwani; Monjori Mitra; Amita Sapru; Shruti Saha; P V Varughese; Rajeev Zachariah Kompithra; Sanjay Gandhi
Journal:  Hum Vaccin Immunother       Date:  2021-08-24       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.